Medicine Supply Notification: Supply issues with multiple GLP-1 RA products
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre-filled pen Dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection in a prefilled pen Liraglutide (Victoza®) 6mg/ml solution for injection in a pre-filled pen. MSN/2024/031 Tier 3 – [...]
The post Medicine Supply Notification: Supply issues with multiple GLP-1 RA products appeared first on Community Pharmacy England.
Recent Comments